Jason S. Fisherman
Directeur Général chez Synkine Therapeutics, Inc.
Profil
Jason S.
Fisherman founded Synthesis Capital in 2007, where he worked as Managing Director from 2012 to 2018 and Synkine Therapeutics, Inc. in 2018, where he is working as President & Chief Executive Officer from 2018.
Dr. Fisherman also currently works at White Cube Management LLC, as Managing Director from 2007 and AlloMek Therapeutics LLC, as Director from 2018.
Dr. Fisherman also formerly worked at C4 Therapeutics, Inc., as President, Chief Executive Officer & Director in 2016, Spherics, Inc., as Chairman, Advent International LP, as Managing Director from 1994 to 2007, Enzon Pharmaceuticals, Inc., as Senior Director-Medical Research from 1991 to 1994, ILEX Oncology, Inc., as Director, Exelixis, Inc., as Director, Anadys Pharmaceuticals, Inc., as Director, Achillion Pharmaceuticals, Inc., as Independent Director from 2000 to 2020, Cellzome Ltd., as Director, Aegerion Pharmaceuticals, Inc., as Director from 2005 to 2011, Trident Pharmaceuticals, Inc., as Director, Ampla Pharmaceuticals, Inc., as Director, Prexa Pharmaceuticals, Inc., as Director, Oridion Systems Ltd., as Director from 1997 to 2003, MDeverywhere, Inc., as Director, Nereus Pharmaceuticals, Inc., as Director, Cellzome AG, as Director, TorreyPines Therapeutics, Inc., as Director from 2006 to 2009, TPTX, Inc., as Director from 2000 to 2007, Spear Therapeutics Ltd., as Director, Crucell NV, as Member-Supervisory Board, Dana-Farber Cancer Institute, Inc., as Research Fellow, and National Cancer Institute, as Principal in 1991.
Dr. Fisherman received his doctorate degree from the University of Pennsylvania, undergraduate degree from Yale University, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Postes actifs de Jason S. Fisherman
Sociétés | Poste | Début |
---|---|---|
White Cube Management LLC
White Cube Management LLC Miscellaneous Commercial ServicesCommercial Services White Cube Management LLC provides management services. The private company is based in Boston, MA. | Corporate Officer/Principal | 01/01/2007 |
Synkine Therapeutics, Inc. | Directeur Général | 01/01/2018 |
AlloMek Therapeutics LLC
AlloMek Therapeutics LLC Pharmaceuticals: MajorHealth Technology AlloMek Therapeutics LLC develops and discovers pharmaceutical products for cancer therapies. It offers MEK kinase inhibitors that improve the biopharmaceutical properties of previous MEK inhibitors. The company was founded by Khire R. Uday and Barry Hart in 2010 and is headquartered in Farmington, CT. | Directeur/Membre du Conseil | 01/06/2018 |
Anciens postes connus de Jason S. Fisherman
Sociétés | Poste | Fin |
---|---|---|
ACHILLION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/01/2020 |
Synthesis Capital
Synthesis Capital Investment ManagersFinance Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts. | Directeur Général | 01/12/2018 |
C4 THERAPEUTICS, INC. | Directeur Général | 14/09/2016 |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 29/04/2013 |
AEGERION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 12/04/2011 |
Formation de Jason S. Fisherman
University of Pennsylvania | Doctorate Degree |
Yale University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
ENZON PHARMACEUTICALS, INC. | Health Technology |
EXELIXIS, INC. | Health Technology |
C4 THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 24 |
---|---|
Advent International LP
Advent International LP Investment ManagersFinance Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts. | Finance |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
Spherics, Inc.
Spherics, Inc. Pharmaceuticals: MajorHealth Technology Spherics, Inc. develops pharmaceutical products to address the clinical needs of neurological disorders. Its technology is based on proprietary bio adhesive, biodegradable polymers, enhancers, and coatings. The company has established two distinct drug delivery systems: nano and macro spheres. Spherics was founded by Dr. Edith Mathiowitz in 1997 and is located in Mansfield, MA. | Health Technology |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Cellzome Ltd.
Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Health Technology |
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Trident Pharmaceuticals, Inc.
Trident Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trident Pharmaceuticals, Inc. develops novel biologics for the treatment of autoimmune disorders. The company was founded by Charles M. Cohen and Robin Brown in March 2006 and is headquartered in Boston, MA. | Health Technology |
Ampla Pharmaceuticals, Inc.
Ampla Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ampla Pharmaceuticals, Inc. engages in the drug discovery of novel oral small molecule drugs for treatment of diabetes and metabolism disorders. It also designs and develops biopharmaceutical drugs. The company was founded by James R. Hauske and Eric Bednarski in 2006 and is headquartered in La Jolla, CA. | Health Technology |
Prexa Pharmaceuticals, Inc.
Prexa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prexa Pharmaceuticals, Inc. developed oral small molecule monoamine reuptake inhibitors that act potently at the dopamine transporter. It engaged in developing small molecules designed to enhance the action of the neurotransmitter dopamine, potentially providing new alternatives to treating CNS diseases and disorders such as ADHD, depression, and Parkinson's disease. The company was founded in 2006 and was headquartered in Boston, MA. | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
Oridion Systems Ltd.
Oridion Systems Ltd. Medical SpecialtiesHealth Technology Oridion Systems Ltd. develops medical devices for patient safety monitoring. It produces medical devices (hardware) and patient interfaces (consumables) based on its patented Microstream and Smart Capnography technologies for the enhancement of patient safety and clinical outcomes. It provides solutions for respiratory monitoring and airway management for patients which includes non-incubated patients, premature newborns and clinical environments which includes procedural sedation, pain management, critical care units, post-anesthesia care units, emergency medical services, transport and alternate care. It operates in Jerusalem, Israel, Needham, Massachusetts and the United States of America. The company was founded by Yacov Bubis in 1987 and is headquartered in Jerusalem, Israel. | Health Technology |
MDeverywhere, Inc.
MDeverywhere, Inc. Packaged SoftwareTechnology Services MDeverywhere, Inc. provides physician revenue cycle management and medical billing software solutions. It offers claim submission, electronic eligibility verification, payment posting, claim follow-up, denial management, insurance rule creation, insurance contract definition, patient recalls, and appointment reminder calls. The company was founded by Lloyd A. Hey and David T. Fetterolf in 1995 and is headquartered in Durham, NC. | Technology Services |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Commercial Services |
Cellzome AG
Cellzome AG Miscellaneous Commercial ServicesCommercial Services Cellzome AG provides drug discovery services. It is a research company with proprietary proteomics technology for target and lead identification and a drug discovery program in Alzheimer's disease. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Commercial Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Health Technology |
TPTX, Inc. | Commercial Services |
White Cube Management LLC
White Cube Management LLC Miscellaneous Commercial ServicesCommercial Services White Cube Management LLC provides management services. The private company is based in Boston, MA. | Commercial Services |
Spear Therapeutics Ltd.
Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom. | Health Technology |
Synthesis Capital
Synthesis Capital Investment ManagersFinance Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts. | Finance |
AlloMek Therapeutics LLC
AlloMek Therapeutics LLC Pharmaceuticals: MajorHealth Technology AlloMek Therapeutics LLC develops and discovers pharmaceutical products for cancer therapies. It offers MEK kinase inhibitors that improve the biopharmaceutical properties of previous MEK inhibitors. The company was founded by Khire R. Uday and Barry Hart in 2010 and is headquartered in Farmington, CT. | Health Technology |
Synkine Therapeutics, Inc. |